Celldex Therapeutics (CLDX) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

Celldex Therapeutics Revenue Highlights

Latest Revenue (Y)

$6.88M

Latest Revenue (Q)

$2.50M

Main Segment (Y)

Grant

Main Geography (Y)

Grant

Celldex Therapeutics Revenue by Period

Celldex Therapeutics Revenue by Year

Date	Revenue	Change
2023-12-31	$6.88M	192.02%
2022-12-31	$2.36M	-49.32%
2021-12-31	$4.65M	-37.30%
2020-12-31	$7.42M	107.61%
2019-12-31	$3.57M	-62.54%
2018-12-31	$9.54M	-25.15%
2017-12-31	$12.74M	87.78%
2016-12-31	$6.79M	23.83%
2015-12-31	$5.48M	52.82%
2014-12-31	$3.59M	-12.77%
2013-12-31	$4.11M	-63.30%
2012-12-31	$11.20M	20.91%
2011-12-31	$9.27M	-80.20%
2010-12-31	$46.79M	208.25%
2009-12-31	$15.18M	103.61%
2008-12-31	$7.46M	46.10%
2007-12-31	$5.10M	3.48%
2006-12-31	$4.93M	59.67%
2005-12-31	$3.09M	-54.97%
2004-12-31	$6.86M	48.04%
2003-12-31	$4.63M	-30.90%
2002-12-31	$6.70M	100.39%
2001-12-31	$3.35M	338.40%
2000-12-31	$763.20K	-48.55%
1999-12-31	$1.48M	-32.57%
1998-12-31	$2.20M	83.33%
1997-12-31	$1.20M	9.09%
1996-12-31	$1.10M	-72.50%
1995-12-31	$4.00M	-42.86%
1994-12-31	$7.00M	-22.22%
1993-12-31	$9.00M	-

Celldex Therapeutics generated $6.88M in revenue during NA 2023, up 192.02% compared to the previous quarter, and up 72.16% compared to the same period a year ago.

Celldex Therapeutics Revenue by Quarter

Date	Revenue	Change
2024-06-30	$2.50M	1501.28%
2024-03-31	$156.00K	-96.22%
2023-12-31	$4.13M	172.31%
2023-09-30	$1.52M	466.04%
2023-06-30	$268.00K	-72.29%
2023-03-31	$967.00K	-40.05%
2022-12-31	$1.61M	296.31%
2022-09-30	$407.00K	149.69%
2022-06-30	$163.00K	-6.32%
2022-03-31	$174.00K	-47.75%
2021-12-31	$333.00K	117.65%
2021-09-30	$153.00K	-95.60%
2021-06-30	$3.48M	408.03%
2021-03-31	$685.00K	-81.91%
2020-12-31	$3.79M	466.77%
2020-09-30	$668.00K	183.05%
2020-06-30	$236.00K	-91.35%
2020-03-31	$2.73M	207.55%
2019-12-31	$887.00K	62.45%
2019-09-30	$546.00K	-23.64%
2019-06-30	$715.00K	-49.82%
2019-03-31	$1.43M	-19.22%
2018-12-31	$1.76M	87.46%
2018-09-30	$941.00K	-65.94%
2018-06-30	$2.76M	-32.08%
2018-03-31	$4.07M	17.71%
2017-12-31	$3.46M	-11.93%
2017-09-30	$3.92M	2.48%
2017-06-30	$3.83M	149.61%
2017-03-31	$1.53M	-18.14%
2016-12-31	$1.87M	-15.59%
2016-09-30	$2.22M	59.83%
2016-06-30	$1.39M	6.60%
2016-03-31	$1.30M	-27.25%
2015-12-31	$1.79M	74.56%
2015-09-30	$1.03M	-52.89%
2015-06-30	$2.18M	348.15%
2015-03-31	$486.00K	-67.10%
2014-12-31	$1.48M	34.15%
2014-09-30	$1.10M	85.98%
2014-06-30	$592.00K	42.31%
2014-03-31	$416.00K	-32.90%
2013-12-31	$620.00K	-36.73%
2013-09-30	$980.00K	910.31%
2013-06-30	$97.00K	-95.98%
2013-03-31	$2.41M	-33.81%
2012-12-31	$3.65M	17.15%
2012-09-30	$3.11M	54.95%
2012-06-30	$2.01M	-17.43%
2012-03-31	$2.43M	-0.04%
2011-12-31	$2.43M	3.00%
2011-09-30	$2.36M	21.06%
2011-06-30	$1.95M	-22.42%
2011-03-31	$2.52M	-93.33%
2010-12-31	$37.72M	1466.49%
2010-09-30	$2.41M	-18.40%
2010-06-30	$2.95M	-20.52%
2010-03-31	$3.71M	-21.55%
2009-12-31	$4.73M	17.44%
2009-09-30	$4.03M	50.09%
2009-06-30	$2.69M	-28.05%
2009-03-31	$3.73M	24.87%
2008-12-31	$2.99M	26.73%
2008-09-30	$2.36M	20.21%
2008-06-30	$1.96M	1230.83%
2008-03-31	$147.40K	-91.43%
2007-12-31	$1.72M	-

Celldex Therapeutics generated $2.50M in revenue during Q2 2024, up 1501.28% compared to the previous quarter, and up 258.32% compared to the same period a year ago.

Celldex Therapeutics Revenue Breakdown

Celldex Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Service	$278.00K	$56.00K	$2.30M	$473.00K	-
Grant	$6.61M	$2.30M	$5.12M	$3.10M	-
Product development and licensing agreements	-	-	$31.00K	-	-
Contracts and grants	-	-	$4.62M	-	-

Celldex Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Grant (95.96%), and Service (4.04%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Dec 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Grant	$3.19M	$154.00K	$5.39M	$252.00K	$967.00K	$1.59M	$153.00K	$3.45M	$682.00K	$3.78M	$656.00K	$236.00K	$442.00K	$793.00K	$491.00K	$520.00K	-	-	-	-
Service	$3.00K	$2.00K	$262.00K	$16.00K	$26.00K	-	$26.00K	$3.00K	$4.00K	$12.00K	$-1.00K	$2.29M	$94.00K	$55.00K	$195.00K	-	-	-	-	-
Product development and licensing agreements	-	-	-	-	-	-	-	-	$30.00K	$2.00K	-	-	-	-	-	-	-	-	-	-
Contracts and grants	-	-	-	-	-	-	$407.00K	$163.00K	$144.00K	$332.00K	-	-	-	-	-	-	-	-	-	-

Celldex Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Grant (99.91%), and Service (0.09%).

Celldex Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Service	$56.00K	$2.30M	$473.00K	$3.34M	-
Grant	$2.30M	$5.12M	$3.10M	$6.20M	-
Contracts and grants	-	$4.62M	-	-	-
Product development and licensing agreements	-	$31.00K	-	-	-

Celldex Therapeutics's latest annual revenue breakdown by geography, as of Dec 22: Grant (97.62%), and Service (2.38%).

Celldex Therapeutics Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TVTX	Travere Therapeutics	$145.24M	$62.90M
IMTX	Immatics	$54.00M	$30.45M
IDYA	IDEAYA Biosciences	$23.39M	-
ANAB	AnaptysBio	$17.16M	$30.02M
MGTX	MeiraGTx	$14.02M	$10.91M
RVMD	Revolution Medicines, Inc. Warrant	$11.58M	-
RNA	Avidity Biosciences	$9.56M	$2.04M
CYTK	Cytokinetics	$7.53M	$463.00K
CLDX	Celldex Therapeutics	$6.88M	$2.50M
SWTX	SpringWorks Therapeutics	$5.45M	$59.73M
CRNX	Crinetics Pharmaceuticals	$4.01M	-
FIXX	Q32 Bio	$1.16M	-
KRTX	Karuna Therapeutics	$654.00K	-
KROS	Keros Therapeutics	$151.00K	$37.00K
ALXO	ALX Oncology	-	-
COGT	Cogent Biosciences	-	-
BCAB	BioAtla	-	$11.00M
DAWN	Day One Biopharmaceuticals	-	$20.07M
AVTE	Aerovate Therapeutics	-	-
DICE	DICE Therapeutics	-	-
DYN	Dyne Therapeutics	-	-
CERE	Cerevel Therapeutics	-	-
VTYX	Ventyx Biosciences	-	-
EWTX	Edgewise Therapeutics	-	-

CLDX Revenue FAQ

What is Celldex Therapeutics’s yearly revenue?

Celldex Therapeutics's yearly revenue for 2023 was $6.88M, representing an increase of 192.02% compared to 2022. The company's yearly revenue for 2022 was $2.36M, representing a decrease of -49.32% compared to 2021. CLDX's yearly revenue for 2021 was $4.65M, representing a decrease of -37.30% compared to 2020.

What is Celldex Therapeutics’s quarterly revenue?

Celldex Therapeutics's quarterly revenue for Q2 2024 was $2.5M, a 1501.28% increase from the previous quarter (Q1 2024), and a 832.09% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $156K, a -96.22% decrease from the previous quarter (Q4 2023), and a -83.87% decrease year-over-year (Q1 2023). CLDX's quarterly revenue for Q4 2023 was $4.13M, a 172.31% increase from the previous quarter (Q3 2023), and a 156.11% increase year-over-year (Q4 2022).

What is Celldex Therapeutics’s revenue growth rate?

Celldex Therapeutics's revenue growth rate for the last 3 years (2021-2023) was 47.99%, and for the last 5 years (2019-2023) was 92.64%.

What are Celldex Therapeutics’s revenue streams?

Celldex Therapeutics's revenue streams in c 23 are Service, and Grant. Service generated $278K in revenue, accounting 4.04% of the company's total revenue, up 396.43% year-over-year. Grant generated $6.6M in revenue, accounting 95.96% of the company's total revenue, up 187.05% year-over-year.

What is Celldex Therapeutics’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Celldex Therapeutics was Grant. This segment made a revenue of $6.6M, representing 95.96% of the company's total revenue.